TY - JOUR

T1 - Biomarkører for kardiovaskulær sygdom ved type 2-diabetes

AU - Krogh, Sara Kull

AU - Andersen, Andreas

AU - Knop, Filip Krag

AU - Vilsbøll, Tina

PY - 2019

Y1 - 2019

N2 - Patients with Type 2 diabetes have an increased risk of cardiovascular disease. However, there exists a considerable heterogeneity in cardiovascular risk in this patient population. A heterogeneity, which may escape the predictive capability of established clinical risk scores. In this context, cardiovascular biomarkers are of significant interest as potential clinical tools to guide risk stratification of patients. Studies have identified N-terminal pro-B-type natriuretic peptide and high-sensitivity cardiac troponin T of particular potential in patients with Type 2 diabetes.

AB - Patients with Type 2 diabetes have an increased risk of cardiovascular disease. However, there exists a considerable heterogeneity in cardiovascular risk in this patient population. A heterogeneity, which may escape the predictive capability of established clinical risk scores. In this context, cardiovascular biomarkers are of significant interest as potential clinical tools to guide risk stratification of patients. Studies have identified N-terminal pro-B-type natriuretic peptide and high-sensitivity cardiac troponin T of particular potential in patients with Type 2 diabetes.

KW - Biomarkers/analysis

KW - Cardiovascular Diseases/complications

KW - Diabetes Mellitus, Type 2/complications

KW - Humans

KW - Prognosis

KW - Risk Assessment

KW - Risk Factors

KW - Troponin T

M3 - Tidsskriftartikel

C2 - 30821245

VL - 181

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

M1 - V10180711

ER -